Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Slides:



Advertisements
Similar presentations
First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix.
Advertisements

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.
Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors  Limor Helpman, M.D., Mario E. Beiner, M.D., Sarit Aviel-Ronen,
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.
Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
Infertility evaluation and treatment among women in the United States
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience  Kutluk Oktay, M.D.,
Michael M. Alper, M.D.  Fertility and Sterility 
Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
Robotic-assisted surgery in gynecologic oncology
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Oocyte cryopreservation
Two interesting cases of ovarian pregnancy after in vitro fertilization–embryo transfer and its successful laparoscopic management  Selvaraj Priya, M.D.,
Gadolinium radiologic contrast is a useful alternative for hysterosalpingography in patients with iodine allergy  Dorette Noorhasan, M.D., Michael J.
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a.
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis  Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Effect of letrozole at 2. 5 mg or 5
Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to.
Results of centralized Asherman surgery, 2003–2013
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.
Eva Balkenende, Taghride Dahhan, M. D. , Fulco van der Veen, M. D, Ph
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
Current approach to fertility preservation by embryo cryopreservation
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Fertility and Sterility
A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 
In vitro fertilization and breast cancer: is there cause for concern?
Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects  Kutluk Oktay, M.D., Ph.D., Giuliano Bedoschi,
Effectiveness of highly purified human menopausal gonadotropin vs
Effect of first line cancer treatment on the ovarian reserve and follicular density in girls under the age of 18 years  Meryam El Issaoui, M.D., Veronica.
S. Samuel Kim, M.D.  Fertility and Sterility 
Lindsay M. Mains, M. D. , Babak Vakili, M. D. , Yves Lacassie, M. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Fertility and Sterility: an evaluation
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.
Genetic evaluation procedures at sperm banks in the United States
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study  Ahmed Badawy, M.D., Aboubakr.
In vitro sildenafil citrate use as a sperm motility stimulant
Which patients pursue fertility preservation treatments
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Presentation transcript:

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients  Volkan Turan, M.D., Giuliano Bedoschi, M.D., Fred Moy, Ph.D., Kutluk Oktay, M.D.  Fertility and Sterility  Volume 100, Issue 6, Pages 1681-1685.e1 (December 2013) DOI: 10.1016/j.fertnstert.2013.08.030 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Time interval from surgery to chemotherapy in patients undergoing two cycles versus single cycle. After log rank test, no difference was found between two groups (P=.176). Fertility and Sterility 2013 100, 1681-1685.e1DOI: (10.1016/j.fertnstert.2013.08.030) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Configuration of all breast cancer patients in this study. Fertility and Sterility 2013 100, 1681-1685.e1DOI: (10.1016/j.fertnstert.2013.08.030) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.